HealthTech Award : Pixium Vision récompensé pour son Système Prima au MedTech Forum
21 avr. 2021 06h00 HE | Pixium Vision
HealthTech Award : Pixium Vision récompensé pour son Système Prima au MedTech Forum Paris, le 21 avril 2021 – 18.00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), société...
Pixium Vision receives HealthTech Award for Prima System at the MedTech Forum
21 avr. 2021 06h00 HE | Pixium Vision
Pixium Vision receives HealthTech Award for Prima System at the MedTech Forum Paris, France, April 21, 2021 – 18.00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics...
Pixium Vision annonce le tirage d’une nouvelle tranche de 1,5 M€ de valeur nominale dans le cadre du contrat de financement avec ESGO
19 avr. 2021 14h00 HE | Pixium Vision
Pixium Vision annonce le tirage d’une nouvelle tranche de 1,5 M€ de valeur nominale dans le cadre du contrat de financement avec ESGO Paris, le 19 avril 2021 – 20h00 CET – Pixium Vision (FR0011950641...
Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1.5 million, under the financing contract with ESGO
19 avr. 2021 14h00 HE | Pixium Vision
Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1.5 million, under the financing contract with ESGO Paris, 19 April 2021 – 8.00 p.m. CET – Pixium Vision...
Pixium-color-2600x800.png
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021.
18 avr. 2021 13h00 HE | Pixium Vision
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 – 6:00 p.m. CEST - Pixium Vision...
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera
07 avr. 2021 01h00 HE | Pixium Vision
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera Study is the last clinical step before seeking market approval in Europe in dry AMDBionic vision...
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima
07 avr. 2021 01h00 HE | Pixium Vision
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima Cette étude est la dernière étape clinique avant la demande d’autorisation de mise sur le...
Pixium-color-2600x800.png
Termination of the business combination with Second Sight Medical Products, Inc.
02 avr. 2021 19h30 HE | Pixium Vision
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private placement recently announced and closed by Second Sight Medical...
Pixium-color-2600x800.png
Pixium Vision announces new compelling results with Prima System demonstrating integration of prosthetic and natural vision
30 mars 2021 01h00 HE | Pixium Vision
Data mark a major step forward in treatment of atrophic AMD Results confirm the safety and stability of the Prima System implant over 24-30 months follow-upPrima System pivotal PRIMAvera study ongoing...
Pixium Vision prend acte des termes du communiqué de presse publié par Second Sight Medical Products, Inc. Paris, France, le 24 mars 2021 - Pixium Vision (Euronext Growth Paris - FR0011950641) (« Pixium ») prend acte des termes du commun
24 mars 2021 20h00 HE | Pixium Vision
Acknowledgment of the terms of the press release issued by Second Sight Medical Products, Inc. Paris, France, March 24, 2021 – Pixium Vision (Euronext Growth Paris - FR0011950641) (“Pixium”)...